本页面由Tiger Trade Technology Pte. Ltd.提供服务

CINGULATE INC.

5.55
+0.22004.13%
盘后5.50-0.0489-0.88%19:30 EDT
成交量:23.47万
成交额:127.74万
市值:8,070.70万
市盈率:-1.56
高:5.55
开:5.35
低:5.18
收:5.33
52周最高:11.89
52周最低:3.16
股本:1,454.18万
流通股本:1,411.18万
量比:1.67
换手率:1.66%
股息:- -
股息率:- -
每股收益(TTM):-3.5600
每股收益(LYR):-4.4408
净资产收益率:-198.74%
总资产收益率:-66.94%
市净率:3.44
市盈率(LYR):-1.25

数据加载中...

公司资料

公司名字:
CINGULATE INC.
交易所:
NASDAQ
成立时间:
2012
员工人数:
14
公司地址:
1901 West 47th Place,Kansas City,Kansas,United States
邮编:
66205
电话:
传真:
- -
简介:
Cingulate Inc.于2012年12月14日在特拉华州成立。该公司是一家生物制药公司,利用其专有的精准定时释放药物递送平台,为注意缺陷多动障碍和焦虑症开发下一代产品。其主要候选药物CTx-1301和CTx-1302旨在作为每日一次的多动症兴奋剂药物,同时也在开发CTx-2103,一种每日一次的丁螺环酮制剂,用于治疗焦虑症。

董事

名称
职位
John A. Roberts
Chairman of the Board and Independent Director
Bryan Lawrence
Independent Director
Jeffrey S. Ervin
Independent Director
Zhanpeng Jiang
Independent Director
Peter J. Werth
Director

股东

名称
职位
Shane J. Schaffer
Chief Executive Officer and Director
Jennifer L. Callahan
Executive Vice President, Chief Financial Officer & Secretary
Bryan Downey
Executive Vice President and Chief Commercial Officer
Matthew N. Brams
Executive Vice President and Chief Medical Officer
Nilay D. Patel
Executive Vice President, Chief Legal Officer & Chief Compliance Officer
Raul R. Silva
Executive Vice President and Chief Science Officer